ArticleScience China. Life sciences2020
The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.
Article in Science China. Life sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 21 citations in OpenAlex.
- Global patterns of phylogenetic diversity and transmission of bat coronavirus.Science China. Life sciences · 2023Article
- SARS-CoV-2 variants, immune escape, COVID-19 vaccine, and therapeutic strategies.Science China. Life sciences · 2023Article
- First COVID-19 lockdown resulted in most respiratory viruses disappearing among hospitalised children, with the exception of rhinoviruses.Acta paediatrica (Oslo, Norway : 1992) · 2022Article
- Evolutionary dynamics of the severe acute respiratory syndrome coronavirus 2 genomes.Medical review (2021) · 2022Review
- Evolutionary analysis and lineage designation of SARS-CoV-2 genomes.Science bulletin · 2021Article
- The high diversity of SARS-CoV-2-related coronaviruses in pangolins alerts potential ecological risks.Zoological research · 2021Article
- The concordance between the evolutionary trend and the clinical manifestation of the two SARS-CoV-2 variants.National science review · 2021Article
- Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2.Cell discovery · 2021Article
- Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.Science China. Life sciences · 2021Review
Corrections and comments
- Comment on
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.